{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:15:31Z","timestamp":1789060531358,"version":"build-2803163510"},"reference-count":59,"publisher":"CSIRO Publishing","issue":"5","license":[{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":879,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,17]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioid use disorder is a public health concern in Australia. Opioid agonist treatment (OAT) is effective at treating and minimising harm from opioid use disorder, yet is underused in Australia due to client barriers. Although these barriers have been reported, the barriers that are most important to clients is unclear. The aim of this paper was to determine the most important OAT barriers to Australian clients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional, self-completed survey was given to 204 opioid-dependent clients who attended needle and syringe sites in Australia. Participants were given 15 OAT barrier statements, which they answered using a 5-point Likert scale (1\u00a0=\u00a0strongly disagree, 2\u00a0=\u00a0disagree, 3\u00a0=\u00a0neutral, 4\u00a0=\u00a0agree and 5\u00a0=\u00a0strongly agree). The Likert scale data are presented using the count method and the mean Likert scores (for the whole sample and for subgroups).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The two methods determined that the four most important barriers to OAT were stigma, lack of support services, no flexibility and enjoy using opioids. Furthermore, those who used prescription opioids (compared with heroin) were female or non-binary (compared with male), were not currently using OAT (compared with current OAT), were younger (compared with older) and had high dependence scores (compared with low dependence scores) were impacted more by certain OAT barriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Policies around improving support services, reducing stigma and increasing flexibility would be beneficial to reduce barriers to OAT in Australia. Second, certain groups were more vulnerable to OAT barriers, emphasising the importance to better tailor opioid treatment programs to these specific populations to increase treatment engagement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/py22269","type":"journal-article","created":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T17:55:12Z","timestamp":1679248512000},"page":"445-454","source":"Crossref","is-referenced-by-count":12,"title":["Identifying the most common barriers to opioid agonist treatment in an Australian setting"],"prefix":"10.1071","volume":"29","author":[{"given":"Natasha Yvonne","family":"Hall","sequence":"first","affiliation":[{"name":"ASchool of Health and Social Development, Deakin University, Burwood, Vic., Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Le","sequence":"additional","affiliation":[{"name":"BPublic Health and Preventative Medicine, Monash University, Melbourne, Vic., Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Abimanyi-Ochom","sequence":"additional","affiliation":[{"name":"ASchool of Health and Social Development, Deakin University, Burwood, Vic., Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree","family":"Teesson","sequence":"additional","affiliation":[{"name":"CFaculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Mihalopoulos","sequence":"additional","affiliation":[{"name":"BPublic Health and Preventative Medicine, Monash University, Melbourne, Vic., Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"67","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"key":"2025102821532780600_R2","unstructured":"Australian Institute of Health and Welfare (2021b) National opioid pharmacotherapy statistics annual data collection \u2013 Table PRESCRIBER2: ratio of clients to prescriber, by prescriber type and state\/territory, 2021 [Online]. (Australian Government: Canberra) Available at https:\/\/www.aihw.gov.au\/reports\/alcohol-other-drug-treatment-services\/national-opioid-pharmacotherapy-statistics-2019\/contents\/prescribers [Accessed 01\/02\/2023]"},{"key":"2025102821532780600_R3","unstructured":"Australian Institute of Health and Welfare (2022) National opioid pharmacotherapy statistics annual data collection [Online]. (AIHW: Canberra) Available at https:\/\/www.aihw.gov.au\/reports\/alcohol-other-drug-treatment-services\/national-opioid-pharmacotherapy-statistics-2019\/contents\/dosing-points [Accessed 05\/04\/2022]"},{"key":"2025102821532780600_R5","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/00952990.2011.596982","article-title":"Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial.","volume":"37","author":"Back","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"2025102821532780600_R6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108959","article-title":"Tracing the affordances of long-acting injectable depot buprenorphine: a qualitative study of patients\u2019 experiences in Australia.","volume":"227","author":"Barnett","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"2025102821532780600_R7","doi-asserted-by":"publisher","DOI":"10.1509\/jmkr.38.2.143.18840","article-title":"Response styles in marketing research: a cross-national investigation.","volume":"38","author":"Baumgartner","year":"2001","journal-title":"Journal of Marketing Research"},{"key":"2025102821532780600_R8","doi-asserted-by":"publisher","first-page":"E344","DOI":"10.9778\/cmajo.20140089","article-title":"Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis.","volume":"3","author":"Bawor","year":"2015","journal-title":"CMAJ Open"},{"key":"2025102821532780600_R9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0740-5472(03)00038-2","article-title":"Improving entry to methadone maintenance among out-of-treatment injection drug users.","volume":"24","author":"Booth","year":"2003","journal-title":"Journal of Substance Abuse Treatment"},{"key":"2025102821532780600_R11","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1080\/10826084.2016.1188951","article-title":"Internalized stigma among people who inject drugs.","volume":"51","author":"Cama","year":"2016","journal-title":"Substance Use & Misuse"},{"key":"2025102821532780600_R12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211033","article-title":"Psychological distress mediated the effects of self-stigma on quality of life in opioid-dependent individuals: a cross-sectional study.","volume":"14","author":"Chang","year":"2019","journal-title":"PLoS ONE"},{"key":"2025102821532780600_R13","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16071299","article-title":"Negative impacts of self-stigma on the quality of life of patients in methadone maintenance treatment: the mediated roles of psychological distress and social functioning.","volume":"16","author":"Cheng","year":"2019","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"2025102821532780600_R14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/15560350903543915","article-title":"Self-efficacy and substance use outcomes for women in single-gender versus mixed-gender group treatment.","volume":"5","author":"Cummings","year":"2010","journal-title":"Journal of Groups in Addiction & Recovery"},{"key":"2025102821532780600_R15","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2010.10.021","article-title":"Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001\u20132009.","volume":"115","author":"Darke","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"key":"2025102821532780600_R16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3109\/10826084.2010.501655","article-title":"Heroin use, dependence, and attitudes to treatment in non-treatment-seeking heroin users: a pilot study.","volume":"46","author":"Dean","year":"2011","journal-title":"Substance Use & Misuse"},{"key":"2025102821532780600_R17","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.addbeh.2011.01.004","article-title":"Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness.","volume":"36","author":"Deering","year":"2011","journal-title":"Addictive Behaviors"},{"key":"2025102821532780600_R18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease.","volume":"379","author":"Degenhardt","year":"2012","journal-title":"The Lancet"},{"key":"2025102821532780600_R19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"5","author":"Degenhardt","year":"2018","journal-title":"The Lancet Psychiatry"},{"key":"2025102821532780600_R20","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jval.2020.01.007","article-title":"Investigation into the effects of using normal distribution theory methodology for Likert scale patient-reported outcome data from varying underlying distributions including floor\/ceiling effects.","volume":"23","author":"DeWees","year":"2020","journal-title":"Value in Health"},{"key":"2025102821532780600_R21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1080\/09595239996284","article-title":"An evaluation of community methadone services in Victoria, Australia: results of a client survey.","volume":"18","author":"Ezard","year":"1999","journal-title":"Drug and Alcohol Review"},{"key":"2025102821532780600_R22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11920-007-0046-2","article-title":"Why buprenorphine is so successful in treating opiate addiction in France.","volume":"9","author":"Fatseas","year":"2007","journal-title":"Current Psychiatry Reports"},{"key":"2025102821532780600_R24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence.","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatric Services"},{"key":"2025102821532780600_R25","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.sapharm.2013.07.006","article-title":"Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.","volume":"10","author":"Gidman","year":"2014","journal-title":"Research in Social and Administrative Pharmacy"},{"key":"2025102821532780600_R26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000189787","article-title":"Severity of dependence scale as a diagnostic tool for heroin and cocaine dependence.","volume":"15","author":"Gonz\u00e1lez-S\u00e1iz","year":"2009","journal-title":"European Addiction Research"},{"key":"2025102821532780600_R27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4603(87)90002-5","article-title":"An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure.","volume":"12","author":"Gossop","year":"1987","journal-title":"Addictive Behaviors"},{"key":"2025102821532780600_R28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1046\/j.1360-0443.1995.9056072.x","article-title":"The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users.","volume":"90","author":"Gossop","year":"1995","journal-title":"Addiction"},{"key":"2025102821532780600_R29","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1080\/10826080500259497","article-title":"Users\u2019 experiences of heroin and methadone treatment.","volume":"40","author":"Gourlay","year":"2005","journal-title":"Substance Use & Misuse"},{"key":"2025102821532780600_R30","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2007.02.009","article-title":"The women\u2019s recovery group study: a stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling.","volume":"90","author":"Greenfield","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"2025102821532780600_R31","doi-asserted-by":"publisher","DOI":"10.1186\/s13011-020-00312-3","article-title":"A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.","volume":"15","author":"Haffajee","year":"2020","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"2025102821532780600_R32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108651","article-title":"Barriers to accessing opioid substitution treatment for opioid use disorder: a systematic review from the client perspective.","volume":"221","author":"Hall","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"2025102821532780600_R33","unstructured":"Health and Human Services Victoria (2020) Policy for maintenance pharmacotherapy for opioid dependence. Available at https:\/\/www.health.vic.gov.au\/publications\/policy-for-maintenance-pharmacotherapy-for-opioid-dependence [Accessed 1\/03\/2023]"},{"key":"2025102821532780600_R34","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1365-2929.2004.02012.x","article-title":"Likert scales: how to (ab)use them.","volume":"38","author":"Jamieson","year":"2004","journal-title":"Medical Education"},{"key":"2025102821532780600_R35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","article-title":"Co-occurring substance use and mental disorders among adults with opioid use disorder.","volume":"197","author":"Jones","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"key":"2025102821532780600_R36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108464","article-title":"Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001-2018: implications for treatment systems and potential impact on client outcomes.","volume":"219","author":"Jones","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"2025102821532780600_R38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/00006199-199003000-00019","article-title":"Treating ordinal scales as interval scales: an attempt to resolve the controversy.","volume":"39","author":"Knapp","year":"1990","journal-title":"Nursing Research"},{"key":"2025102821532780600_R39","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1046\/j.1360-0443.2000.9556975.x","article-title":"The effects of offering free treatment to street-recruited opioid injectors.","volume":"95","author":"Kwiatkowski","year":"2000","journal-title":"Addiction (Abingdon, England)"},{"key":"2025102821532780600_R41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/00223890802107925","article-title":"The best\u2013worst scaling approach: an alternative to Schwartz\u2019s values survey.","volume":"90","author":"Lee","year":"2008","journal-title":"Journal of Personality Assessment"},{"key":"2025102821532780600_R42"},{"key":"2025102821532780600_R43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/09595230801935706","article-title":"Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.","volume":"27","author":"Madden","year":"2008","journal-title":"Drug and Alcohol Review"},{"key":"2025102821532780600_R44","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.","volume":"372","author":"Mathers","year":"2008","journal-title":"The Lancet"},{"key":"2025102821532780600_R45","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.","volume":"375","author":"Mathers","year":"2010","journal-title":"The Lancet"},{"key":"2025102821532780600_R46","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","article-title":"Gender differences in a clinical trial for prescription opioid dependence.","volume":"45","author":"McHugh","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"2025102821532780600_R47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jsat.2019.01.019","article-title":"Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: a needs assessment for decision making support.","volume":"100","author":"Muthulingam","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"2025102821532780600_R48","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.","volume":"378","author":"Nelson","year":"2011","journal-title":"The Lancet"},{"key":"2025102821532780600_R49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jsat.2014.06.006","article-title":"Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users.","volume":"48","author":"Nielsen","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"2025102821532780600_R50","doi-asserted-by":"publisher","first-page":"e79","DOI":"10.1093\/pm\/pnz213","article-title":"Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings.","volume":"21","author":"Nielsen","year":"2020","journal-title":"Pain Medicine"},{"key":"2025102821532780600_R51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.drugalcdep.2006.08.017","article-title":"Women-only and mixed-gender drug abuse treatment programs: Service needs, utilization and outcomes.","volume":"87","author":"Niv","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"2025102821532780600_R52","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10459-010-9222-y","article-title":"Likert scales, levels of measurement and the \u201claws\u201d of statistics.","volume":"15","author":"Norman","year":"2010","journal-title":"Advances in Health Sciences Education"},{"key":"2025102821532780600_R53","unstructured":"North Richmond Community Health (2022) Medically supervised injecting room [Online]. (North Richmond Community Health: Melbourne) Available at https:\/\/nrch.com.au\/services\/medically-supervised-injecting-room\/ [Accessed 10\/02\/2022]"},{"key":"2025102821532780600_R54","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1037\/tps0000250","article-title":"An exploratory study of sex and gender differences in demographic, psychosocial, clinical, and substance use treatment characteristics of patients in outpatient opioid use disorder treatment with buprenorphine.","volume":"7","author":"Parlier-Ahmad","year":"2021","journal-title":"Translational Issues in Psychological Science"},{"key":"2025102821532780600_R55","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/jcpt.13114","article-title":"Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management.","volume":"45","author":"Pergolizzi","year":"2020","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"2025102821532780600_R56","unstructured":"Pharmaceutical Benefits Scheme (2022) PBS Schedule search for \u201cbuprenorphine\u201d [Online]. (Department of Health: Canberra) Available at https:\/\/www.pbs.gov.au\/pbs\/search?term=buprenorphine&search-type=medicines&analyse=false [Accessed 30\/03\/2022]"},{"key":"2025102821532780600_R57","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jsat.2010.12.001","article-title":"The relative effectiveness of women-only and mixed-gender treatment for substance-abusing women.","volume":"40","author":"Prendergast","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"key":"2025102821532780600_R58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/09595230500286039","article-title":"The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).","volume":"24","author":"Ross","year":"2005","journal-title":"Drug and Alcohol Review"},{"key":"2025102821532780600_R59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jsat.2006.01.003","article-title":"Person-related and treatment-related barriers to alcohol treatment.","volume":"30","author":"Saunders","year":"2006","journal-title":"Journal of Substance Abuse Treatment"},{"key":"2025102821532780600_R60","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"2025102821532780600_R63","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/j.drugpo.2013.07.007","article-title":"Impact of methadone maintenance on health utility, health care utilization and expenditure in drug users with HIV\/AIDS.","volume":"24","author":"Tran","year":"2013","journal-title":"International Journal of Drug Policy"},{"key":"2025102821532780600_R64","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/09687630600997527","article-title":"Valuing methadone takeaway doses: the contribution of service-user perspectives to policy and practice.","volume":"14","author":"Treloar","year":"2007","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"2025102821532780600_R65","unstructured":"United Nations Office on Drugs and Crime (2008) Drug policy and results in Australia. Available at https:\/\/www.unodc.org\/documents\/data-and-analysis\/Studies\/Drug_Policy_Australia_Oct2008.pdf [Accessed 1\/03\/2023]"},{"key":"2025102821532780600_R66"},{"key":"2025102821532780600_R67","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0558","article-title":"Health, polysubstance use, and criminal justice involvement among adults with varying levels of opioid use.","volume":"1","author":"Winkelman","year":"2018","journal-title":"JAMA Network Open"}],"container-title":["Australian Journal of Primary Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/29\/5\/445%20\/691712\/py22269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/py\/article-pdf\/29\/5\/445%20\/691712\/py22269.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:53:43Z","timestamp":1761702823000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/py\/article\/29\/5\/445%20\/86145\/Identifying-the-most-common-barriers-to-opioid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10,17]]}},"URL":"https:\/\/doi.org\/10.1071\/py22269","relation":{},"ISSN":["1448-7527","1836-7399"],"issn-type":[{"value":"1448-7527","type":"print"},{"value":"1836-7399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]}}}